These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32511543)

  • 1. Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease.
    Mudd PA; Crawford JC; Turner JS; Souquette A; Reynolds D; Bender D; Bosanquet JP; Anand NJ; Striker DA; Martin RS; Boon ACM; House SL; Remy KE; Hotchkiss RS; Presti RM; OHalloran JA; Powderly WG; Thomas PG; Ellebedy AH
    medRxiv; 2020 May; ():. PubMed ID: 32511543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.
    Mudd PA; Crawford JC; Turner JS; Souquette A; Reynolds D; Bender D; Bosanquet JP; Anand NJ; Striker DA; Martin RS; Boon ACM; House SL; Remy KE; Hotchkiss RS; Presti RM; O'Halloran JA; Powderly WG; Thomas PG; Ellebedy AH
    Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33187979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    Reynolds D; Vazquez Guillamet C; Day A; Borcherding N; Vazquez Guillamet R; Choreño-Parra JA; House SL; O'Halloran JA; Zúñiga J; Ellebedy AH; Byers DE; Mudd PA
    J Immunol; 2021 Sep; 207(5):1229-1238. PubMed ID: 34348975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Karaba AH; Zhou W; Hsieh LL; Figueroa A; Massaccesi G; Rothman RE; Fenstermacher KZJ; Sauer L; Shaw-Saliba K; Blair PW; Robinson ML; Leung S; Wesson R; Alachkar N; El-Diwany R; Ji H; Cox AL
    Clin Infect Dis; 2022 Jan; 74(2):254-262. PubMed ID: 34013339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
    Sims JT; Krishnan V; Chang CY; Engle SM; Casalini G; Rodgers GH; Bivi N; Nickoloff BJ; Konrad RJ; de Bono S; Higgs RE; Benschop RJ; Ottaviani S; Cardoso A; Nirula A; Corbellino M; Stebbing J
    J Allergy Clin Immunol; 2021 Jan; 147(1):107-111. PubMed ID: 32920092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-cell atlas of the peripheral immune response to severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martinez-Colon GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    medRxiv; 2020 Apr; ():. PubMed ID: 32511639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
    Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.
    Carolan LA; Rockman S; Borg K; Guarnaccia T; Reading P; Mosse J; Kelso A; Barr I; Laurie KL
    J Virol; 2015 Dec; 90(6):2838-48. PubMed ID: 26719259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients.
    Ruetsch C; Brglez V; Crémoni M; Zorzi K; Fernandez C; Boyer-Suavet S; Benzaken S; Demonchy E; Risso K; Courjon J; Cua E; Ichai C; Dellamonica J; Passeron T; Seitz-Polski B
    Front Med (Lausanne); 2020; 7():603961. PubMed ID: 33585507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
    Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
    Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
    Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.
    Giamarellos-Bourboulis EJ; Netea MG; Rovina N; Akinosoglou K; Antoniadou A; Antonakos N; Damoraki G; Gkavogianni T; Adami ME; Katsaounou P; Ntaganou M; Kyriakopoulou M; Dimopoulos G; Koutsodimitropoulos I; Velissaris D; Koufargyris P; Karageorgos A; Katrini K; Lekakis V; Lupse M; Kotsaki A; Renieris G; Theodoulou D; Panou V; Koukaki E; Koulouris N; Gogos C; Koutsoukou A
    Cell Host Microbe; 2020 Jun; 27(6):992-1000.e3. PubMed ID: 32320677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokine storm in avian influenza].
    Us D
    Mikrobiyol Bul; 2008 Apr; 42(2):365-80. PubMed ID: 18697437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.